Results 111 to 120 of about 123,989,332 (223)

Patients with Alpha-1 Antitrypsin Deficiency: Disease Management Considerations

open access: yes, 2008
Alpha-1 antitrypsin (AAT) deficiency is a genetic disorder that leads to decreased circulating levels of AAT, which significantly increases the risk of serious lung and liver disease.
Brian L. Tiep, Rick Carter, Brian L Tiep
core   +1 more source

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study

open access: yes, 2016
Miriam Barrecheguren,1,2 Mónica Monteagudo,3 Pere Simonet,3–5 Carl Llor,6 Esther Rodriguez,1,7 Jaume Ferrer,1,2,7 Cristina Esquinas,1 Marc Miravitlles1,2,7 1Department of Pneumology, Vall d´Hebron University Hospital, 2Medicine ...
Llor C   +7 more
core  

Alpha-1-Antitrypsin-Mangel

open access: yes, 2009
ZusammenfassungDer Alpha-1-Antitrypsin-Mangel ist eine auto-somal-kodominant vererbbare Krankheit mit einer Prävalenz von 1:2000–1:5000. Typische klinische Merkmale sind die frühzeitige Entwicklung einer chronisch obstruktiven Lungenerkrankung mit ...
M. Dahlheim, N. Schwerk, M. Bredt
core   +1 more source

The use of real-time PCR for the diagnosis of Z gene Pi mutation in patients with alpha-1 antitrypsin deficiency

open access: yesЯкутский медицинский журнал
The aim of this study is to develop a method for diagnosing PiZ mutation associated with alpha-1 antitrypsin deficiency using real-time PCR technology.A simple method is proposed for detecting one of the most frequent mutations of the Pi gene PiZ ...
E. V. Tapiev   +5 more
doaj   +1 more source

Vascular Pathology in Alpha 1 Antitrypsin Deficient Chronic Obstructive Pulmonary Disease and Emphysema Patients: Case Reports [PDF]

open access: yes
Matthew Gordon,1,* Andrew J Gangemi,1,* Eric L Sandwith,2,* Maruti Kumaran,3,* Friedrich Kueppers1,* 1Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA; 2HCA Florida
Gordon M   +4 more
core  

Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency-associated lung disease

open access: yesCochrane Database of Systematic Reviews
Alpha-1 antitrypsin (AAT) is a protein produced by the liver that stops certain enzymes from harming body tissues, especially in the lungs. AAT deficiency (AATD) is a genetic condition that can manifest clinically as chronic obstructive pulmonary disease (COPD), causing cough and breathlessness.
Glaister, Patrick   +5 more
openaire   +2 more sources

Alpha-1 antitrypsin and serum albumin levels in tear fluid of healthy subjects and in persons with conjunctival diseases

open access: yesIndian Journal of Ophthalmology, 1988
Alpha-1 antitrypsin and serum albumin levels were measured in the tear fluids in 81 healthy subjects and 142 patients with conjunctival diseases. The levels of the two proteins were independent of age and sex.
Sen D, Sarin G, Mathur M
doaj  

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes

open access: yes, 2015
Sanjay H Chotirmall,1 Mazen Al-Alawi,2 Thomas McEnery,2 Noel G McElvaney2 1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 2Department of Respiratory Medicine, Beaumont Hospital, Dublin, Republic of Ireland Abstract ...
Chotirmall SH   +3 more
core  

Alpha 1 Antitrypsin Deficiency (AATD) Financial Cost

open access: yes
Explore the financial burdens of Alpha-1 Antitrypsin Deficiency, offering insights into treatment costs, economic impact, and innovative healthcare ...
Azhar ul Haque Sario
core   +1 more source

Home - About - Disclaimer - Privacy